介入性腫瘤學市場：按手術、癌症類型和最終用戶分類 - COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響 - 2023-2030 年全球預測

全球介入性腫瘤市場預計將以7.84%的複合年成長率大幅成長，2023年達到50.4336億美元，到2030年將達到85.6682億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球介入性腫瘤市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 介入性腫瘤學的全球市場規模和預測是多少？

2.在預測期內，COVID-19對全球介入性腫瘤學市場的阻礙因素和影響為何？

3. 在預測期內，全球介入性腫瘤學市場需要投資哪些產品/細分市場/應用/領域？

4.全球介入腫瘤市場的競爭策略是什麼？

5. 全球介入腫瘤市場的技術趨勢和法律規範是什麼？

6.全球介入腫瘤市場主要廠商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球介入性腫瘤市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 全球癌症發生率不斷上升，老年人口迅速增加
    • 增加政府介入腫瘤學的支出
    • 偏好微創手術
  • 抑制因素
    • 缺乏訓練有素的腫瘤幹預醫生
  • 機會
    • 在門診提供介入性腫瘤學的好處
    • 介入性腫瘤學新技術進展
  • 任務
    • 替代治療的存在
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 依程序分類的介入性腫瘤學市場

• 消融
• 顆粒栓塞
• 放射治療

第7章 依癌症類型分類的介入性腫瘤學市場

• 骨轉移
• 乳癌
• 腎癌
• 肝癌
• 肺癌
• 攝護腺癌

第8章 介入腫瘤學市場：依最終用戶分類

• 門診手術中心
• 醫院
• 研究和學術機構

第9章 美洲介入腫瘤市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太介入腫瘤學市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲介入腫瘤市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Interventional Oncology Market is forecasted to grow significantly, with a projected USD 5,043.36 million in 2023 at a CAGR of 7.84% and expected to reach a staggering USD 8,566.82 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Interventional Oncology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Interventional Oncology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Procedure, market is studied across Ablation, Particle Embolization, and Radiation Therapy. The Particle Embolization is projected to witness significant market share during forecast period.

Based on Cancer Type, market is studied across Bone Metastasis, Breast Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, and Prostate Cancer. The Bone Metastasis is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Ambulatory Surgery Centers, Hospitals, and Research & Academic Institutes. The Ambulatory Surgery Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Interventional Oncology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Interventional Oncology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Interventional Oncology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Interventional Oncology Market?

4. What is the competitive strategic window for opportunities in the Global Interventional Oncology Market?

5. What are the technology trends and regulatory frameworks in the Global Interventional Oncology Market?

6. What is the market share of the leading vendors in the Global Interventional Oncology Market?

7. What modes and strategic moves are considered suitable for entering the Global Interventional Oncology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Interventional Oncology Market, by Procedure, 2022 vs 2030
• 4.3. Interventional Oncology Market, by Cancer Type, 2022 vs 2030
• 4.4. Interventional Oncology Market, by End-Users, 2022 vs 2030
• 4.5. Interventional Oncology Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in incidence of cancer across the globe and surge in geriatric population
    • 5.1.1.2. Increase in government expenditures for interventional oncology
    • 5.1.1.3. Preference for minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of trained interventional oncologists
  • 5.1.3. Opportunities
    • 5.1.3.1. Benefits of providing interventional oncology in an outpatient setting
    • 5.1.3.2. New technological advancements for interventional oncology
  • 5.1.4. Challenges
    • 5.1.4.1. Presence of alternative therapies
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Interventional Oncology Market, by Procedure

• 6.1. Introduction
• 6.2. Ablation
• 6.3. Particle Embolization
• 6.4. Radiation Therapy

7. Interventional Oncology Market, by Cancer Type

• 7.1. Introduction
• 7.2. Bone Metastasis
• 7.3. Breast Cancer
• 7.4. Kidney Cancer
• 7.5. Liver Cancer
• 7.6. Lung Cancer
• 7.7. Prostate Cancer

8. Interventional Oncology Market, by End-Users

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Hospitals
• 8.4. Research & Academic Institutes

9. Americas Interventional Oncology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Interventional Oncology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Interventional Oncology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2022 VS 2030
• FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
• FIGURE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
• FIGURE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
• FIGURE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
• FIGURE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 16. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 29. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 46. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 101. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 113. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 116. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 146. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 147. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 148. INTERVENTIONAL ONCOLOGY MARKET LICENSE & PRICING